Literature DB >> 19843093

Functional expression of cystic fibrosis transmembrane conductance regulator in mouse chondrocytes.

Haitao Liang1, Lin Yang, Tonghui Ma, Yong Zhao.   

Abstract

1. Cystic fibrosis transmembrane conductance regulator (CFTR) is well known for its role in the cystic fibrosis (CF). Recent studies have shown that CF patients and CFTR-deficient mice exhibit a severe abnormal skeletal phenotype, indicating that CFTR may play a role in bone development and pathophysiological processes. However, it is not known whether CFTR has a direct or indirect effect on bone formation. The aim of the present study was to detect the expression and function of CFTR in mouse chondrocytes. 2. Reverse transcription-polymerase chain reaction, western blotting and immunofluorescence were used to characterize the expression of CFTR in primary isolated mouse chondrocytes. Expression of CFTR mRNA and protein was detectable in mouse chondrocytes. Importantly, whole-cell patch-clamp analysis demonstrated that CFTR in mouse chondrocytes is functional as a cAMP-dependent Cl(-) channel that is inhibited by CFTRinh-172. 3. Thus, the results of the present study demonstrate that functional CFTR is expressed in mouse chondrocytes, which offers essential evidence for the potential direct role of CFTR in physiological and pathological processes of bone.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19843093     DOI: 10.1111/j.1440-1681.2009.05319.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  8 in total

1.  Cystic Fibrosis Transmembrane Conductance Regulator in Sarcoplasmic Reticulum of Airway Smooth Muscle. Implications for Airway Contractility.

Authors:  Daniel P Cook; Michael V Rector; Drake C Bouzek; Andrew S Michalski; Nicholas D Gansemer; Leah R Reznikov; Xiaopeng Li; Mallory R Stroik; Lynda S Ostedgaard; Mahmoud H Abou Alaiwa; Michael A Thompson; Y S Prakash; Ramaswamy Krishnan; David K Meyerholz; Chun Y Seow; David A Stoltz
Journal:  Am J Respir Crit Care Med       Date:  2016-02-15       Impact factor: 21.405

Review 2.  Cystic Fibrosis and the Nervous System.

Authors:  Leah R Reznikov
Journal:  Chest       Date:  2016-11-19       Impact factor: 9.410

Review 3.  The Homeostasis of Cartilage Matrix Remodeling and the Regulation of Volume-Sensitive Ion Channel.

Authors:  Zhiqin Deng; Xiaoqiang Chen; Zicong Lin; Murad Alahdal; Daping Wang; Jianquan Liu; Wencui Li
Journal:  Aging Dis       Date:  2022-06-01       Impact factor: 9.968

4.  The emerging chondrocyte channelome.

Authors:  Richard Barrett-Jolley; Rebecca Lewis; Rebecca Fallman; Ali Mobasheri
Journal:  Front Physiol       Date:  2010-10-14       Impact factor: 4.566

Review 5.  Bone fragility in patients affected by congenital diseases non skeletal in origin.

Authors:  L Masi; S Ferrari; M K Javaid; S Papapoulos; D D Pierroz; M L Brandi
Journal:  Orphanet J Rare Dis       Date:  2021-01-06       Impact factor: 4.123

6.  Osteoblast CFTR inactivation reduces differentiation and osteoprotegerin expression in a mouse model of cystic fibrosis-related bone disease.

Authors:  Michael S Stalvey; Katrina L Clines; Viktoria Havasi; Christopher R McKibbin; Lauren K Dunn; W Joon Chung; Gregory A Clines
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

7.  Reduced bone length, growth plate thickness, bone content, and IGF-I as a model for poor growth in the CFTR-deficient rat.

Authors:  Michael S Stalvey; Viktoria Havasi; Katherine L Tuggle; Dezhi Wang; Susan Birket; Steve M Rowe; Eric J Sorscher
Journal:  PLoS One       Date:  2017-11-30       Impact factor: 3.240

Review 8.  Inflammatory Diseases and Growth: Effects on the GH-IGF Axis and on Growth Plate.

Authors:  Francesca Cirillo; Pietro Lazzeroni; Chiara Sartori; Maria Elisabeth Street
Journal:  Int J Mol Sci       Date:  2017-08-31       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.